Etiology and treatment of circumscribed sclerodermarevisited



Cite item

Full Text

Abstract

There was a clinical and laboratory study of the efficacy of complex treatment with Longidaza, a Russian enzyme drug, in 30
patients suffering from circumscribed scleroderma. High efficacy of treatment for different clinical forms of circumscribed scleroderma
using this method was proved. A positive effect of the complex therapy on the results of ultrasonic skin examination in the
affection foci and individual blood immunology indices was revealed.

References

  1. Кубанова А.А., Тихонова Л.И. Дерматовенерология в России. Реальность и перспективы. Вест.дерматол. и венерол. 2004; 2: 4-11.
  2. Коробейникова Э.А., Мартынова Л.М., Анисимова А.В. Кли- нические аспекты ограниченной склеродермии. Рос. журн. кожн. и венерич. болезней, 2004; 3: 27-29.
  3. Караулов А.В. Клиническая иммунология и аллергология. М.: Медицина, 2002; 238-269.
  4. Довжанский С.И. Клинико-иммунологические параллели при ограниченной и системной склеродермии. Рос. журн. кожн. и венерич. болезней, 2002; 4: 26-29.
  5. Wenzel J. Scleroderma and malignancy. Mechanisms of interrelationship. Eur J Dermatol 2002; 12 (3): 296-300.
  6. Sellheyer K., Krahl D. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms. J Cutan Pathol 2008; 35(4): 366-372.
  7. Kaji K., Fujimoto M., Hasegawa M. et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007; 46 (1): 25-28.
  8. Billet S.E., Grando S.A., Pittelkow M.R. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006; 39 (7): 617-630.
  9. Gunawardena H., Wedderburn L.R., North J. et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 2008; 47 (3): 324-328.
  10. Heymann W.R. Paraneoplastic autoimmune multiorgan syndrome. J Am Acad Dermatol 2004; 51 (4): 631-632.
  11. Moore R.L., Devere T.S. Epidermal manifestations of internal malignancy. Dermatol Clin 2008; 26 (1): 17-29.
  12. Garcia-Rio I., Delgado-Jimenez Y., Alonso-Perez A. et al. Radiationinduced morphea. J Eur Acad Dermatol Venereol 2003; 17 (3): 6-24.
  13. Tournillac I., Dandurand M., Guillot B. Bullous lichen sclerosus after radiotherapy. Ann Dermatol Venereol 1998; 125 (2): 121-123.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Dvornikov A.S., Kruglova L.S., Dvornikov A.S., Kruglova L.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies